Starpharma (OTCMKTS:SPHRY) Trading Down 12.3%

Starpharma Holdings Limited (OTCMKTS:SPHRYGet Rating) was down 12.3% during mid-day trading on Wednesday . The company traded as low as $4.52 and last traded at $4.52. Approximately 600 shares were traded during trading, a decline of 54% from the average daily volume of 1,304 shares. The stock had previously closed at $5.15.

The stock’s fifty day moving average price is $5.69 and its 200-day moving average price is $7.00.

About Starpharma (OTCMKTS:SPHRY)

Starpharma Holdings Limited, a biopharmaceutical company, engages in the research, development, and commercialization of dendrimer products for pharmaceutical, life-science, and other applications worldwide. The company offers VivaGel, a non-antibiotic therapy for the management and prevention of bacterial vaginosis.

Featured Stories

Want More Great Investing Ideas?

Receive News & Ratings for Starpharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Starpharma and related companies with MarketBeat.com's FREE daily email newsletter.